Literature DB >> 7470758

Clonidine distribution in the rat: temporal relationship between tissue levels and blood pressure response.

E L Conway, B Jarrott.   

Abstract

1. The time course of the distribution of clonidine (20 microgram/kg, i.v.) was determined in the rat by use of a sensitive and specific radioimmunoassay, and was compared with the hypotensive response following this dose. 2. Levels of clonidine were determined in tissues at 2 min, corresponding to the beginning of the hypotensive phase of the drug, and then at 10, 30 and 120 min during recovery of blood pressure to the pre-dose level. The peak tissue concentrations of clonidine were found at 2 min, after which they declined in a mono-exponential manner. The half-lives of clonidine in the various tissues were similar to the half-life of the recovery of blood pressure. 3. Regional variations in clonidine distribution in the brain were not very great; however, the half-life was longer in the corpus striatum and shorter in the cerebellum than in other brain regions. 4. Clonidine concentrations were highest in the kidney and similarly distributed between the cortex and medulla. Concentrations of the drug in other tissues approximated those in brain. 5. Although clonidine is thought to act primarily through the central nervous system, this distribution study shows that at the peak of the hypotensive response less than 2% of the injected dose is present in brain and at least equal concentrations of the drug are found in most peripheral tissues. Thus the possibility of peripheral mechanisms contributing to the hypotensive effect cannot be dismissed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7470758      PMCID: PMC2044444          DOI: 10.1111/j.1476-5381.1980.tb10960.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  Central and peripheral alpha-adrenergic effects of some imidazolidines.

Authors:  P B Timmermans; P A Van Zwieten
Journal:  Eur J Pharmacol       Date:  1977-10-01       Impact factor: 4.432

Review 2.  Central alpha-adrenergic systems as targets for hypotensive drugs.

Authors: 
Journal:  Rev Physiol Biochem Pharmacol       Date:  1978       Impact factor: 5.545

3.  Evidence for an alpha-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane.

Authors:  H Schmitt; S Fenard
Journal:  Eur J Pharmacol       Date:  1971       Impact factor: 4.432

4.  Dopamine in the mesolimbic system of the rat brain: endogenous levels and the effects of drugs on the uptake mechanism and stimulation of adenylate cyclase activity.

Authors:  A S Horn; A C Cuello; R J Miller
Journal:  J Neurochem       Date:  1974-02       Impact factor: 5.372

5.  A generalized computer program for the treatment of data from competitive protein-binding assays including radioimmunoassays.

Authors:  H G Burger; V W Lee; G C Rennie
Journal:  J Lab Clin Med       Date:  1972-08

6.  Pharmacological studies on the hypotensive effects of clonidine.

Authors:  P Bolme; K Fuxe
Journal:  Eur J Pharmacol       Date:  1971-01       Impact factor: 4.432

7.  [Studies on the pharmacokinetics and on the metabolism of 2(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride (St 155)].

Authors:  D Rehbinder; W Deckers
Journal:  Arzneimittelforschung       Date:  1969-02

8.  Lipophilicity and brain disposition of clonidine and structurally related imidazolidines.

Authors:  P B Timmermans; A Brands; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

9.  The physiological disposition of 2(2,6-dichloroanilino)-2-imidazoline (St-155).

Authors:  A K Cho; S H Curry
Journal:  Biochem Pharmacol       Date:  1969-02       Impact factor: 5.858

10.  Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain.

Authors:  J Glowinski; L L Iversen
Journal:  J Neurochem       Date:  1966-08       Impact factor: 5.372

View more
  11 in total

1.  Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence-induced hyperalgesia.

Authors:  Paula E Park; Joel E Schlosburg; Leandro F Vendruscolo; Gery Schulteis; Scott Edwards; George F Koob
Journal:  Addict Biol       Date:  2013-12-13       Impact factor: 4.280

2.  Similar decrease in spontaneous morphine abstinence by methadone and RB 101, an inhibitor of enkephalin catabolism.

Authors:  F Ruiz; M C Fournié-Zaluski; B P Roques; R Maldonado
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

3.  Tissue pharmacokinetics of clonidine in rats.

Authors:  E L Conway; B Jarrott
Journal:  J Pharmacokinet Biopharm       Date:  1982-04

4.  Noradrenergic receptor modulation influences the acoustic parameters of pro-social rat ultrasonic vocalizations.

Authors:  Laura M Grant; Kelsey J Barth; Cagla Muslu; Cynthia A Kelm-Nelson; Vaishali P Bakshi; Michelle R Ciucci
Journal:  Behav Neurosci       Date:  2018-07-09       Impact factor: 1.912

5.  Carrier-mediated uptake of clonidine in cultured human lung cells.

Authors:  Marc Le Vée; Elodie Jouan; Olivier Fardel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-01-19       Impact factor: 3.000

6.  Stimulation of α2-adrenergic receptors in the central nucleus of the amygdala attenuates stress-induced reinstatement of nicotine seeking in rats.

Authors:  Hidetaka Yamada; Adrie W Bruijnzeel
Journal:  Neuropharmacology       Date:  2010-09-18       Impact factor: 5.250

7.  A physiologically based pharmacokinetic model to predict disposition of CYP2D6 and CYP1A2 metabolized drugs in pregnant women.

Authors:  Alice Ban Ke; Srikanth C Nallani; Ping Zhao; Amin Rostami-Hodjegan; Nina Isoherranen; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2013-01-25       Impact factor: 3.922

8.  The α2-adrenergic receptor agonist, clonidine, reduces alcohol drinking in alcohol-preferring (P) rats.

Authors:  Dennis D Rasmussen; Laura Alexander; Julia Malone; David Federoff; Janice C Froehlich
Journal:  Alcohol       Date:  2014-07-14       Impact factor: 2.405

9.  Dipropylacetate-induced quasi-morphine abstinence behaviour in the rat: suppression by alpha 2-adrenoceptor stimulation.

Authors:  J W van der Laan; G Weick; F C Hillen
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Increase in insulin response to glucose in the rat chronically treated with clonidine.

Authors:  K Ishii; S Yamamoto; R Kato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.